文献速递免疫规划

麻疹、腮腺炎和风疹疫苗接种是否与2岁以下儿童抗生素治疗率降低相关?基于丹麦、芬兰、挪威和瑞典的全国登记研究

Is vaccination against measles, mumps, and rubella associated with reduced rates of antibiotic treatments among children below the age of 2 years? Nationwide register-based study from Denmark, Finland, Norway, and Sweden.
PubMed 文献 · Vaccine · 2024-03-20

这项基于丹麦、芬兰、挪威和瑞典的登记队列研究纳入831287名接种过DTaP3但未接种MMR疫苗的儿童,随访至2岁。

要点

  • 各国aHR:丹麦0.92,芬兰0.92,挪威0.84,瑞典0.87。
  • 阴性对照分析提示残余混杂,非特异性效应临床重要性有限。

核心结论

  • 在北欧国家,接种MMR疫苗后抗生素治疗率降低11%。
  • 阴性对照分析提示研究结果受残余混杂影响。
  • MMR疫苗的潜在非特异性效应对于北欧门诊治疗的轻度感染的临床和公共卫生重要性有限。

研究设计与样本

  • 基于登记数据的队列研究,纳入丹麦、芬兰、挪威和瑞典831287名接种过DTaP3但未接种MMR疫苗的儿童,随访至2岁。
  • 使用Cox比例风险回归,以年龄为基本时间尺度,疫苗接种状态为时变暴露,估计协变量调整的风险比(aHR)和逆概率治疗加权(IPTW)HR。
  • 汇总估计采用随机效应Meta分析。

主要发现

  • 阴性对照暴露分析比较接种DTaP3与两剂DTaP的儿童,观察到更强的有益关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 阴性对照分析提示研究结果受残余混杂影响。
  • MMR疫苗的潜在非特异性效应对于北欧门诊治疗的轻度感染的临床和公共卫生重要性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Previous studies have shown that vaccination against measles, mumps, and rubella (MMR) may have beneficial non-specific effects, reducing the risk of infections not targeted by the vaccine. We investigated if MMR vaccine given after the third dose of diphtheria-tetanus-acellular pertussis vaccine (DTaP3), was associated with reduced rates of antibiotic treatments. METHODS: Register-based cohort study following children from the age of recommended MMR vaccination until age 2 years. We included 831,287 children born in Denmark, Finland, Norway, and Sweden who had received DTaP3 but not yet MMR vaccine. Cox proportional hazards regression with age as the underlying timescale and vaccination status as a time-varying exposure was used to estimate covariate-adjusted Hazard Ratios (aHRs) and inverse probability of treatment weighted (IPTW) HRs of antibiotic treatments. Summary estimates were calculated using random-effects meta-analysis. RESULTS: Compared with only having received DTaP3, receipt of MMR vaccine after DTaP3 was associated with reduced rates of antibiotic treatments in all countries: the aHR was 0.92 (0.91-0.93) in Denmark, 0.92 (0.90-0.94) in Finland, 0.84 (0.82-0.85) in Norway, and 0.87 (0.85-0.90) in Sweden, yielding a summary estimate of 0.89 (0.85-0.93). A stronger beneficial association was seen in a negative control exposure analysis comparing children vaccinated with DTaP3 vs two doses of DTaP. CONCLUSIONS: Across the Nordic countries, receipt of MMR vaccine after DTaP3 was associated with an 11% lower rate of antibiotic treatments. The negative control analysis suggests that the findings are affected by residual confounding. Findings suggest that potential non-specific effects of MMR vaccine are of limited clinical and public health importance for the milder infections treated out-of-hospital in the Nordic setting.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Gehrt L, Englund H, Laake I, et al. Is vaccination against measles, mumps, and rubella associated with reduced rates of antibiotic treatments among children below the age of 2 years? Nationwide register-based study from Denmark, Finland, Norway, and Sweden. Vaccine. 2024. PMID: 38508926. doi:10.1016/j.vaccine.2024.03.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。